You are here

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Phoenix, Arizona, 85004 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer's Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Mild-to-Moderate Alzheimer's disease

- Probable AD (National Institute of Neurological and Communicative Disorders and Stroke
and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) and
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV)

- MMSE score 10-24 inclusive

- Computerized tomography (CT) san or magnetic resonance imaging (MRI) consistent with
AD

- Caregiver who cares for the patient at least 5 days per week

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Anti-dementia drugs including cholinesterase-inhibitors or N-methyl-D-aspartate
receptor (NMDA) receptor antagonists within 90 days

- Other causes of dementia

- Other primary psychiatric or neurological disorders

- Unstable medical illnesses or significant hepatic or renal disease

NCT00675623
Pfizer
Completed
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now